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Summary Photaffinity labelling (PAL) with [32P]8-azido-cAMP and polyacrylamide gel electrophoresis
(PAGE) has been used to identify three specific cAMP-binding proteins (cAMP-BPs) within cytosols derived
from the centre and periphery of 32 human colorectal cancers and from related adjacent (less than 5 cm from
the tumour) and distant (more than 5 cm from the tumour) microscopically benign mucosa. By
immunoprecipitation with specific anti-RI and anti-RII antibodies these proteins have subsequently been
characterised as a single form of RI (48 kDa) and two forms of RII (50 and 52 kDa). The relative expression
of isoforms in each specimen has been quantified by laser densitometry. There was significantly more RI
expressed in both tumour centre and periphery than in either adjacent or distant mucosa (P<0.008 by
Wilcoxon signed-rank test). There was no significant difference in relative RI expression between tumour
centre and periphery, or between adjacent and distant mucosa. There was no association between relative RI
expression and Dukes' stage. Poorly differentiated tumours expressed significantly more RI than those that
were either moderately or well differentiated (P = 0.016 by Mann-Whitney U-test). This study is the first to
have characterised cAMP-BPs within human colorectal tissues and has demonstrated that colorectal cancers,
and in particular those of poor histological grade, relatively overexpress RI when compared with related
benign mucosa.
Cyclic adenosine 3', 5'-monophosphate (cAMP) mediates the
effects of a wide range of hormones and interacts with other
secondary messenger systems (Suppatone et al., 1988; Ball et
al., 1990) to exert control over basic cell processes such as
proliferation and differentiation (Cho-Chung, 1989). Cyclic
AMP binds to and activates its dependent protein kinase,
also known as protein kinase A (PK-A) (Walsh, 1968). In its
inactive form PK-A exists as a tetramer of two regulatory
(R) subunits that bind cAMP (also known as cAMP-binding
proteins or cAMP-BPs) and two catlytic (C) subunits that
possess serine/threonine kinase activity. On binding of four
cAMPs the holoenzyme dissociates into its component parts,
allowing free C subunits to phosphorylate target proteins.
Regulatory subunits play an important role in modulating
kinase activity by localising it to different cellular compart-
ments (DeCamilli et al., 1986; Cho-Chung et al., 1988;
Linask & Green, 1989) and by acting as pseudosubstrate in
the absence of cAMP. R subunits are extremely
heterogeneous, with at least four separate R subunit genes
now being recognised (Lee et al., 1983; Jahnsen et al., 1986a,b;
Scott et al., 1987; Sandberg et al., 1988), and with yet more
diversity at the mRNA level (Oyen et al., 1989; Sandberg et
al., 1990). In addition to their regulatory role, R subunits
may act independently to control gene expression, perhaps by
entering the nucleus (Cho-Chung et al., 1988) and binding to
DNA (Sikorska et al., 1988; Wu & Wang, 1989). In general,
RI isoforms predominate in proliferating, developing
(Lorimer et al., 1987; Gentleman et al., 1989a) transformed
(Gharret et al., 1986) and malignant cells (Gentleman et al.,
1989b), while RII isoforms may programme for
differentiation (Haddox et al., 1979).
Previous work has shown that human colorectal cancers
bind significantly more cAMP than related benign mucosa,
suggesting that the development of colorectal cancer is
associated with an abnormality in cAMP-BP expression
(Bradbury et al., 1991). Furthermore, cAMP analogues
inhibit the growth and promote the differentiation of a
human colorectal cancer cell line together with a reduction in
RI and an increase in RII expression (Tagliaferri et al.,
1988). To date, the pattern of cAMP-BPs within human
colorectal tissues has not been examined. The aims of the
present study, therefore, were to characterise and compare
R-subunit expression within benign and malignant human
colorectal tissues and to examine differences in R subunits
within tumours of different stage and histological grade.
Method
Patients and tissues
Specimens were obtained from 32 patients undergoing elec-
tive surgery for colorectal cancer, from which sufficient
material was available for study after histological
confirmation of disease. Operative specimens were obtained
fresh from theatre and kept on ice until processed. Samples
were taken from tumour centre and periphery and from both
adjacent and distant macroscopically normal mucosa. When
sampling tumour, attempts were made to avoid obviously
necrotic or haemorrhagic areas. Operative specimens were
routinely processed for diagnosis, stage and grade (Dukes,
1932). Individual tumour and mucosa samples were also
examined histologically to confirm their malignant or benign
nature. Samples were stored at -70C until use.
Preparation ofcytosols
All procedures were performed at 0-4°C. Approximately
200 mg of tissue was homogenised (Silverson) in 1:10 (w/v)
tissue buffer (pH 7.5) containing 20 mM Tris, 2 mM
magnesium chloride, 10 mM calcium chloride, 1 mM potas-
sium chloride, 16mM hydrochloric acid and 100kIUml1'
aprotinin (Bayer UK). The homogenate was centrifuged at
105,000 g for 1 h at 4°C (Sorvall) and the supernatant used as
cytosol. The protein content of each cytosol was determined
by a spectrophotometric method using Coomassie brilliant
blue (Sigma) (Bradford, 1976). Bovine serum albumin was
used as a standard.
Photoaffinity labelling (PAL) ofcAMP-binding proteins
The method was adapted from that of Pomerantz et al.
(1975). Cytosols of known protein content were diluted with
tissue buffer to a concentration of 1 mg ml-'. Diluted cytosol
(50J1) was incubated with 0.4t4M [32P]8-azido-cAMP (sp. act.
56-62Ci mmol'", ICN Radiochemicals) diluted in MES
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magnesium chloride buffer containing 0.27M mor-
pholinoethanesulphonic acid (MES) (Sigma) and 53 mM
magnesium chloride (Fisons) (15 t1l) and with MES -
magnesium chloride buffer (15 tl) with and without
radioinert 0.4mM cAMP. The final reaction mixtures (80id)
were mixed and incubated in the dark for 1 h at 4°C. Sam-
ples were irradiated with UV light at 254 nm for 5 min at 4°C
(Mineralight UVS- 1) to effect photoincorporation. Sample
buffer containing 3% sodium lauryl sulphate, 15% mercapto-
ethanol, 30 mM Tris, 30% glycerol and 1% saturated
bromophenol blue solution was added (40id). Proteins were
denatured in a water bath at 80°C for 5 min. Aliquots of
40 1I (15 ,Lg of protein) were separated electrophoretically.
Methylated [14CJprotein mixture (Amersham) (20;LI) was used
as a molecular weight marker.
Immunoprecipitation ofcAMP-bindingproteins with specific
monoclonal antibodies
Photoactivated incorporation of V32P]8-azido-cAMP was car-
ried out as above. Radioinert 10 nM cAMP (5 gsl) was added
to the reaction mixture and immunoprecipitation performed
using specific anti-RI and anti-RII antibodies and protein
A-Sepharose. Following two washes with phosphate-buffered
saline, pellets of antigen-antibody complex were solubilised
and subjected to electrophoretic separation.
Polyacrylamide gel electrophoresis
Separating gel contained 12% acrylamide/BIS (Bio-Rad),
4.5% Tris (pH 8.8), 0.05% SDS, 0.08% TEMED (Bio-Rad)
and 0.06% ammonium persulphate (Fisons). Stacking gel
contained 4% acrylamide/BIS, 1.5% Tris (pH 6.8), 0.1%
SDS, 0.1% TEMED and 0.05% ammonium persulphate.
Samples were run at 35 mA per gel.
Transblotting ofcAMP-binding proteins
Transblotting was performed by a method adapted from that
of Towbin (1979). Gels were soaked in transfer buffer con-
taining 25 mM Tris, 0.15 M sodium chloride, 2,UM EDTA
and 0.1% Nonidet NP-40 (Bio-Rad) for 15 min. Electro-
phoretic transfer was conducted overnight at 4°C and at 60 V
with no current limit.
azido-cAMP, co-migrate with R65 in tissue cytosols and to
show only limited displacement with cAMP (data not
shown). It was therefore concluded that this protein
represented albumin within the cytosols and was not a novel
cAMP-BP.
Identification ofR52, 50 and 48 asforms ofRI! and RI
Immunoprecipitation of tumour and mucosa cytosols with
specific antibodies of RI and RII followed by PAL and
PAGE confirmed that R52 and R50 were both forms of RII
and that R48 represented a single form of RI (Figure 2).
These proteins could therefore be termed RII-52, RII-50 and
RI-48 respectively. Immunoprecipitation of commercially
obtained, partially purified animal RI (48 kDa) and RII
(56 kDa) showed these preparations to be extremely
heterogeneous.
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Figure 1 PAL of cAMP-binding proteins in cytosols derived
from tumour and mucosa. - and + denote assays performed in
the absence and presence of excess radioinert cAMP respectively.
TC, tumour centre; TP, tumour periphery; MA, adjacent mucosa;
MD, distant mucosa. The R65 band is present in all four tissue
types and is only partially displaceable by excess radioinert
cAMP. Three main cAMP-BPs are seen - RII-52, RII-50 and
RII-48 - together with minor bands of 44, 37 and 34 kDa.
Binding is higher in tumour than in mucosa with an increase in
the proportion of RI expressed and a reduction in both forms,
but particularly RII-52, of RII.
Preparation ofautoradiographs
Dried, cellophane-wrapped nitrocellulose sheets were placed
in a film canister with Kodak XR film for times depending
on the age and specific activity of the isotope batch being
used. Films were developed and fixed. The relative amounts
of the different cAMP-BP present in each autoradiograph
were quantified by laser densitometry and expressed as a
percentage of the total amount of cAMP-BP present.
Results
Molecular weights ofcAMP-bindingproteins
Several distinct cAMP-BPs were identified in cytosols derived
from both tumours and normal mucosa (Figure 1). By com-
parison with '4C-labelled molecular weight standards these
cAMP-BPs were found to have molecular weights of 52, 50,
48, 44, 37 and 34 kDa and so were initially termed R52, R50,
R48, R44, R37 and R34 respectively. Binding of [32P]8-azido-
cAMP to all moieties could be displaced by the addition of
1,000-fold excess cAMP. In all tissues examined the
predominant forms were R52, R50 and R48, with the other
forms contributing less than 15% of the total cAMP-BPs
present. In most tissues examined a protein of 65 kDa was
also found to bind [32P]8-azido-cAMP and was termed R65.
However, in contrast with the other cAMP-BPs, binding was
only partially displaced by excess radioinert cAMP. Bovine
serum albumin (fraction V) was also found to bind [32P]8-
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Figure 2 Immunoprecipitation and PAL of cAMP-BPs in
tumour periphery (TP) and related adjacent (MA) and distant
(MD) mucosal cytosols obtained from three patients. The same
amount of protein was run in each lane. The two left-hand lanes
demonstrate immunoprecipitation with anti-RI (upper gel) and
anti-RII (lower gel) of commercially obtained, partially purified,
preparations of animal RI (48 kDa) and RII (56 kDa) and show
that these preparations are, in fact, extremely heterogeneous. The
upper gel demonstrates immunoprecipitation of human colorectal
tissues with anti-RI antibody and shows that, although a single
RI band is present in both tumour and mucosal cytosols, RI is
present in greater amounts in tumour than in mucosa in all three
patients. The lower gel demonstrates immunoprecipitation of the
same colorectal tissues with anti-RII antibody and shows both
R52 and R50 to be forms of RII. In addition there is more RII in
the mucosal than the tumour cytosols of all three patients.740 A.W. BRADBURY et al.
Relative overexpression ofRI-48 in tumours
Comparison ofpercentage expression of RI as determined by
laser densitometry of autoradiographs following PAL and
PAGE is shown in Table I. The median value for both the
tumour centre and periphery was higher than for the adja-
cent and distant mucosa, but the range of values for each
group of tissues was large. However, as within each group
tissues were obtained from each individual patient, it is more
illuminating to make paired comparisons. The data for indi-
vidual patients have therefore been plotted in Figures 3 to 5,
making comparisons between both parts of the tumour, both
samples of mucosa and adjacent mucosa and tumour
periphery. The results in Figure 3 show the strong positive
correlation between values in tumour centre and periphery
and the equal distribution of points along the line x =y.
Similar observations were apparent for adjacent and distant
mucosa (Figure 4). However, the correlation in RI expression
between adjacent and tumour periphery is much poorer and
there is a clear tendency for values to be higher in the
tumour periphery (Figure 5). Testing by paired Wilcoxon
rank test showed the percentage RI expression to be
significantly higher in both the centre and periphery of
tumours when compared with both adjacent and distant
mucosa (P<0.008). A plot of the results as a ratio of the
value in adjacent mucosa shows the clear tendency for values
to be higher in tumour (Figure 6).
Relative RI expression in tumours ofdifferent Dukes stage and
histological grade
There was no significant difference in relative RI expression
between tumours of different Dukes stage. However, relative
RI expression was significantly higher in the centre of poorly
differentiated tumours than in the centre of those tumours
that were moderately or well differentiated (P = 0.016 by
Mann-Whitney U-test). There was a similar trend in tumour
periphery, although this did not attain statistical significance
(P = 0.14). There was no difference in RI expression between
well- and moderately differentiated tumours (Table II). RI
expression in adjacent and distant mucosa was not affected
by the stage or grade of the tumour to which they were
related (data not shown).
Discussion
This is the first study to have characterised the pattern of
PK-A R-subunit expression in human colorectal tissues,
although our previous work has shown that the periphery of
human colorectal cancers may possess increased total cAMP-
binding levels (Bradbury et al., 1991). Specific cAMP-BPs
were identified in all the tissues examined and were of three
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Figure 3 Correlation between RI expression in tumour centre
and tumour periphery; r = 0.725, P<0.001. Line represents
x =y.
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FC Table I RI expression in tumour and mucosa expressed as a
percentage of the total cAMP-binding proteins present
Median
Range
Tumour
centre
61.2
33.0-77.5
RI expression (%)
Tumour Adjacent
periphery mucosa
58.7 50.6
26.0-76.0 32.1-72.4
Distant
mucosa
51.7
29.4-70.0
Table II RI expression in tumours of different histological grade
Well- Moderately Poorly
differentiated differentiated differentiated
tumours tumours tumours
(n =2) (n = 21) (n = 9)
Tumour centre
Median 52.8 56.5 68.4
Range 52.1-61.0 38.3-73.0 51.3-77.5
Tumour periphery
Median 57.1 58.6 64.5
Range 56.4-57.8 35.7-74.7 55.4-76.0
Adjacent mucosa
Median 42.1 50.8 50.0
Range 32.1-52.1 33.2-62.0 37.5-72.4
Distant mucosa
Median 48.8 52.3 51.0
Range 43.6-54.0 33.8-65.7 29.4-70.0
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Figure 4 Correlation between RI expression in adjacent and
distant mucosa; r = 0.58, P<0.01. Line represents x =y.
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Figure 5 Correlation between RI expression in tumour periphery
and adjacent mucosa; r= 0.51, P<0.05. Line represents
x =y.PK-A REGULATORY SUBUNIT EXPRESSION 741
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Figure 6 Scatter plot of RI expression in tumour centre, tumour
periphery and distant mucosa expressed as a ratio of percentage
RI expression in adjacent mucosa from the same patient.
Horizontal lines represent median values. Only three specimens of
tumour centre and six specimens of tumour periphery contained
less RI than adjacent mucosa taken from the same patient. In
contrast, there was no consistent difference between adjacent and
distant mucosa.
main types with molecular weights of 48, 50 and 52 kDa.
Other species of low molecular weight were also detected but
constituted less than 15% of the total cAMP-BPs present.
These smaller molecules have been detected by other workers
and are generally considered to be degradation products
(Rannels & Corbin, 1979). Immunoprecipitation with specific
anti-RI and anti-RII antibodies showed that the 48 kDa
moiety was a form of RI, while both the 50 kDa and 52 kDa
moieties were forms of RII. The relationship of RII-50 to
RII-52 is unknown. It is possible that they represent the
dephosphorylated and autophosphorylated forms of RII
respectively (Rangel-Aldao et al., 1979). Alternatively, they
may be separate gene products.
The second novel finding of the study is that there is
significantly more RI-48 in both the centre and periphery of
human colorectal cancers when compared with paired adja-
cent and distant benign mucosa. In contrast, RII-50 and
particularly RII-52 were reduced in cancers. Malignant colo-
rectal tissues therefore relatively overexpress RI-48 when
compared with benign mucosa. To our knowledge, the only
other published work on R-subunit expression in colorectal
tissues was performed by Tagliaferri et al. (1988) on a human
cell line LS-174T. This was found to express predominantly a
47 kDa RI protein but also to express lesser amounts of 52
and 54 kDa RII proteins. Interestingly, treatment with the
cAMP analogue 8-Cl-cAMP resulted in an inhibition of
growth and the promotion of morphological differentiation.
These effects were associated with a reduction in RI but an
increase in RII expression within the cell line. The relation-
ship between these RII isoforms and the RII isoforms
detected in the present study is unknown. However, the same
antibodies were used for detection and so it is possible that
they are, in fact, the same proteins and that differences in
technique account for the small differences observed in
molecular weight. Although cell lines have been relatively
well investigated with regard to cAMP-binding protein pat-
terns, to our knowledge this is the first study to have
examined the pattern of cAMP-binding proteins within a
resected human cancer. Other workers have looked at the
expression of kinase activity within other types of human
tumours, and the results from these studies would appear to
support the observations made in this paper. Fossberg et al.
(1978) found the PKAI/II ratio within a human renal cell
carcinoma to be approximately twice that found in normal
renal cortex. Yasui et al. (1985) found that while normal
human gastric mucosa had a PK-AI/II ratio of 0.2, in xeno-
transplantable human gastric carcinomas it was approxi-
mately 0.6, leading them to conclude that type I PK-A was a
biochemical marker for malignant transformation. The pre-
sent work also shows that RI is particularly highly expressed
in tumour of poor histological grade. This is in contrast to
the studies of Fossberg et al. (1978) and Yasui et al. (1985),
who were unable to demonstrate any association between
type I PK-A kinase activity and histological grade. Taken
together, these results and the present study provide evidence
for excess PK-AI and RI expression in three separate human
malignancies (renal, gastric, colorectal). It is possible,
therefore, that such overexpression is a general phenomenon
associated with carcinogenesis.
The present study also demonstrates a strong correlation
between RI expression in tumour and mucosa from the same
patient, suggesting that the relative overexpression of RI is
superimposed upon a background level of RI expression
which is highly variable between different individuals. It is
interesting to speculate whether these differences reflect
differences in cell proliferation as a hyperproliferative mucosa
is generally proposed as the first detectable step in the pro-
cess of colorectal carcinogenesis and is believed to affect the
entire colon (Terpstra et al., 1987).
In conclusion, this study is the first to have characterised
cAMP-binding protein expression in human colorectal tissues
and has demonstrated that resected human colorectal
cancers, like human colon cancer cell lines, relatively overex-
press RI cAMP-binding protein. Furthermore, a high level of
RI expression is associated with poor histological grade. The
observation that cAMP analogues can inhibit the growth and
promote the differentiation of human colon cancer cell lines
in vitro together with a reduction in RI expression suggests
that such analogues may be able to exert biological control
of colorectal cancers in vivo.
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